MyFinsight
Home
Blog
About
Contact
Proceeds from issuance of
common stock
$22,500K
Proceeds from issuance of
common stock upon...
$15,000K
Proceeds from exercise of
equity awards, net
$88K
Net cash provided by
(used in) financing...
$34,984K
Effect of changes in
exchange rate on cash and...
$102K
Canceled cashflow
$2,604K
Net increase
(decrease) in cash and...
$13,286K
Canceled cashflow
$21,800K
Payment of equity
issuance costs
$1,779K
Payment of warrant
issuance costs
$825K
Stock-based compensation
expense
$3,398K
Depreciation and
amortization expense
$590K
Amortization of debt issuance
cost
$377K
Non-cash lease expense
$323K
Non-cash interest
expense
$25K
Other
-$10K
Net cash used in
operating activities
-$21,794K
Net cash used in
investing activities
-$6K
Canceled cashflow
$4,723K
Net loss
-$19,177K
Accounts payable and
accrued expenses
-$5,398K
Purchases of property and
equipment
$6K
Prepaid expenses and
other current assets
$927K
Non-cash expense from
collaborative arrangements,...
$698K
Lease obligations
-$317K
Back
Back
Cash Flow
Ocugen, Inc. (OCGN)
Ocugen, Inc. (OCGN)
source: myfinsight.com